
Clinical Briefs
Sickle Cell Anemia Guidance Expands Hydroxyurea Access
WHO recommends hydroxyurea for all children and adolescents with sickle cell anemia from 9 months to 19 years, shifting care toward early treatment regardless of symptom history.
Rayan Salih · September 2, 2026 · 7 min
